INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Most active filers · 30d

  1. 01Kurtz George0B / 239S · 10 late239 trades$59.22M
  2. 02SPSaba Capital Management, L.P.68B / 23S · 14 late91 trades$30.01M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07CFCheng Chi Fung0B / 42S42 trades$15.33M
  8. 08RJRubinstein Julie0B / 37S37 trades$6.25M
  9. 09SLSpeiser Michael L0B / 35S35 trades$14.00M
  10. 10RARothblatt Martine A0B / 33S33 trades$5.50M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  5. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  6. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  7. SELLADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
  8. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K

Form 4 transactions

67,560 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
BD
Bashan DrorDirector, PRESIDENT AND CEO
PLXProtalix BioTherapeutics, Inc.
Grant or award
A—
160.0K sh
Sep 3, 2026Sep 4, 2026
Page 396 of 1689
← PrevNext →
traded Sep 3, 2026
+1d
SEC Form 4

Evidence

9
BD
Bashan DrorDirector, PRESIDENT AND CEO
PLXProtalix BioTherapeutics, Inc.
Grant or award
A—
320.0K sh
Sep 3, 2026Sep 4, 2026
traded Sep 3, 2026
+1dSEC Form 4

Evidence

9
GM
Grover MatthewDirector
DTSTData Storage Corp
Option exercise
M—
10.0K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

9
SM
Spanos MikeDirector
CASYCASEYS GENERAL STORES INC
Option exercise
M—
326 sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

9
AJ
Argen JohnDirector
DTSTData Storage Corp
Option exercise
M—
10.0K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

9
SN
Stallone NancyDirector
DTSTData Storage Corp
Option exercise
M—
10.0K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

9
WM
Wessling Erin MEVP & Chief Legal Officer
ELVElevance Health, Inc.
Tax withholding
F$38K
94 sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

9
FE
Forster EliotDirector
PLXProtalix BioTherapeutics, Inc.
Grant or award
A—
17.0K sh
Sep 3, 2026Sep 4, 2026
traded Sep 3, 2026
+1dSEC Form 4

Evidence

9
WI
Wilson IanEXECUTIVE VICE PRESIDENT
AMCRAmcor plc
Option exercise
M—
5,782 sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

9
GS
Gosk Kimberly ShannonEVP & CPO
OTISOtis Worldwide Corp
Tax withholding
F$19K
274 sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

9
CC
Christel Eric CEVP, Chief Financial Officer
BLMNBloomin' Brands, Inc.
Option exercise
M—
25.2K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

9
LK
Lefferts KellyEVP, Chief Legal Officer
BLMNBloomin' Brands, Inc.
Tax withholding
F$37K
3,747 sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

9
MA
Mitchell Uwayne A.Director
DTSTData Storage Corp
Option exercise
M—
10.0K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

9
GM
Grover MatthewDirector
DTSTData Storage Corp
Option exercise
M—
10.0K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

9
LN
Lane NathanDirector
LPSNLIVEPERSON INC
Disposition to issuer
D—
23.4K sh
Sep 4, 2026Sep 4, 2026
traded Sep 4, 2026
+0dSEC Form 4

Evidence

9
BH
Blumenthal Neil HarrisDirector, Co-Chief Executive Officer
WRBYWarby Parker Inc.
Option exercise
M—
44.6K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

9
FD
Frieson DonaldDirector
CASYCASEYS GENERAL STORES INC
Option exercise
M—
326 sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

9
VP
Villanova PatrickChief Financial Officer
BLBLACKLINE, INC.
Option exercise
M—
750 sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

9
MA
Mitchell Uwayne A.Director
DTSTData Storage Corp
Option exercise
M—
10.0K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

9
MA
Maglione Lawrence A.Director
DTSTData Storage Corp
Option exercise
M—
10.0K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

9
BD
Brown Christopher D.Director
MASS908 Devices Inc.
Open-market sale · 10b5-1 plan
SELL$317K
30.0K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

9
BS
Ben Zvi ShmuelDirector
PLXProtalix BioTherapeutics, Inc.
Grant or award
A—
8,500 sh
Sep 3, 2026Sep 4, 2026
traded Sep 3, 2026
+1dSEC Form 4

Evidence

9
BS
Ben Zvi ShmuelDirector
PLXProtalix BioTherapeutics, Inc.
Grant or award
A—
17.0K sh
Sep 3, 2026Sep 4, 2026
traded Sep 3, 2026
+1dSEC Form 4

Evidence

9
CR
Chambers RebeccaChief Financial Officer
VCYTVERACYTE, INC.
Open-market sale · 10b5-1 plan
SELL$51K
1,175 sh
Sep 4, 2026Sep 4, 2026
traded Sep 4, 2026
+0dSEC Form 4

Evidence

9
SC
Stein CliffordDirector
DTSTData Storage Corp
Option exercise
M—
10.0K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

9
WI
Wilson IanEXECUTIVE VICE PRESIDENT
AMCRAmcor plc
Tax withholding
F$24K
514 sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

9
FE
Forster EliotDirector
PLXProtalix BioTherapeutics, Inc.
Grant or award
A—
8,500 sh
Sep 3, 2026Sep 4, 2026
traded Sep 3, 2026
+1dSEC Form 4

Evidence

9
HY
Holton Adam YChief People Officer
GEHCGE HealthCare Technologies Inc.
Tax withholding
F$47K
673 sh
Sep 3, 2026Sep 4, 2026
traded Sep 3, 2026
+1dSEC Form 4

Evidence

9
EC
Estrampes CatherineChief Commer. & Growth Officer
GEHCGE HealthCare Technologies Inc.
Tax withholding
F$36K
508 sh
Sep 3, 2026Sep 4, 2026
traded Sep 3, 2026
+1dSEC Form 4

Evidence

9
EC
Elze ChristianDirector
PLXProtalix BioTherapeutics, Inc.
Grant or award
A—
17.0K sh
Sep 3, 2026Sep 4, 2026
traded Sep 3, 2026
+1dSEC Form 4

Evidence

9
NY
Naos YaronSr. VP & COO
PLXProtalix BioTherapeutics, Inc.
Grant or award
A—
112.0K sh
Sep 3, 2026Sep 4, 2026
traded Sep 3, 2026
+1dSEC Form 4

Evidence

9
WA
Ware J. AnthonyDirector
TRAXFirst Tracks Biotherapeutics, Inc.
Option exercise
M—
10.7K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

9
WA
Ware J. AnthonyDirector
TRAXFirst Tracks Biotherapeutics, Inc.
Option exercise
M—
28.6K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

9
TJ
Tarangelo James J.EVP and CFO
ARMKAramark
Option exercise
M—
8,852 sh
Sep 3, 2026Sep 4, 2026
traded Sep 3, 2026
+1dSEC Form 4

Evidence

9
PV
Pegueros VanessaDirector
LPSNLIVEPERSON INC
Disposition to issuer
D—
22.7K sh
Sep 4, 2026Sep 4, 2026
traded Sep 4, 2026
+0dSEC Form 4

Evidence

9
AJ
Argen JohnDirector
DTSTData Storage Corp
Option exercise
M—
10.0K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

9
CD
Collins John DeNeenCFO and COO
LPSNLIVEPERSON INC
Disposition to issuer
D—
6,260 sh
Sep 4, 2026Sep 4, 2026
traded Sep 4, 2026
+0dSEC Form 4

Evidence

9
VP
Villanova PatrickChief Financial Officer
BLBLACKLINE, INC.
Option exercise
M$11K
750 sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

9
CR
Chambers RebeccaChief Financial Officer
VCYTVERACYTE, INC.
Open-market sale · 10b5-1 plan
SELL$106K
2,477 sh
Sep 4, 2026Sep 4, 2026
traded Sep 4, 2026
+0dSEC Form 4

Evidence

9
GA
Gilboa David AbrahamDirector, Co-Chief Executive Officer
WRBYWarby Parker Inc.
Option exercise
M—
44.6K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence